ISSN: 1744-666X

Journal Home

Journal Guideline

Expert Review of Clinical Immunology Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Clinical Immunology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 66. It has a price of 4000 €. It has an SJR impact factor of 1,136 and it has a best quartile of Q2. It has an SJR impact factor of 1,136.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,136

SJR Impact factor

66

H Index

118

Total Docs (Last Year)

356

Total Docs (3 years)

10402

Total Refs

1559

Total Cites (3 years)

318

Citable Docs (3 years)

4

Cites/Doc (2 years)

88.15

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Experimental Immunology Q2
Cellular Immunology Q2
Clinical and Experimental Allergy Q2
Genes & Immunity Q2
Cellular Microbiology Q2

Compare this journals

Aims and Scope

Best articles by citations

Genotyping in rheumatoid arthritis: a game changer in clinical management?

Insulin: a critical autoantigen and potential therapeutic agent in Type 1 diabetes

The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review

The clinical, humanistic, and economic burden of palmoplantar pustulosis: a structured review

Epileptic seizures as a manifestation of cow's milk allergy: a studied relationship and description of our pediatric experience

Biologics in pediatric Crohn's disease: is it time to move to an earlier therapeutic approach?

Allergy immunotherapy tablet: Grazax¬Æfor the treatment of grass pollen allergy

Anakinra in the treatment of rheumatic disease

Intravenous golimumab in rheumatoid arthritis

CT-P13 in the treatment of rheumatoid arthritis

Pharmacology, clinical efficacy and safety of olopatadine hydrochloride

Advances in proteomic techniques for biomarker discovery in COPD

SHOW MORE ARTICLES

The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook

Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis

Systemic lupus erythematosus, regulatory T cells and pregnancy

In vitrotests of T cell-mediated drug hypersensitivity

Immunology of chronic myeloid leukemia: current concepts and future goals

The evolution of the danger theory

Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy

Epidemiology of major chronic inflammatory immune-related skin diseases in 2019

Filaggrin mutations and atopy: consequences for future therapeutics

Immunosuppressive therapy post-transplantation in children: what the clinician needs to know

Iguratimod for the treatment of rheumatoid arthritis in Japan

Prenatal programming of the innate immune response followingin uteroexposure to inflammation: a sexually dimorphic process?